Company: LBRX
Filing Date: 2025-09-08
Form Type: S-1/A
Source: 0001193125-25-197877
Chunk: 409

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-09-08
Form: S-1/A
Chunk 409
---
 common stock. The Stock Split reduced the number of shares of the Company’s issued and outstanding common stock, as well as
the numbers of shares reserved and available for future issuance and underlying outstanding options to purchase common stock. No fractional shares were distributed as a result of the reverse stock split, and stockholders were entitled to a cash
payment in lieu of fractional shares. The Stock Split did not affect the par values per share or total authorized common stock. Accordingly, all shares of common stock and per share amounts for all periods presented in the financial statements have
been adjusted retroactively, where applicable, to reflect the Stock Split.

F-56

16,666,667 Shares

Common Stock

Leerink Partners

Piper Sandler

Stifel

Through and including , 2025 (the 25th day after the date of this prospectus), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This delivery requirement is in addition to a dealer’s obligation to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription.

PART II INFORMATION NOT REQUIRED IN PROSPECTUS Item 13. Other Expenses of Issuance and Distribution. The following table indicates the expenses to be incurred in connection with the offering described in this registration statement, other than the underwriting discounts and commissions, all of which will be paid by us. All amounts are estimated except the U.S. Securities and Exchange Commission, or SEC, registration fee, the Financial Industry Regulatory Authority, Inc., or FINRA, filing fee, and the Nasdaq listing fee.

|                                                |     | Amount |           |
|:-----------------------------------------------|:----|:-------|----------:|
| SEC registration fee                           |     | $      |    46,951 |
| FINRA filing fee                               |     |        |    46,500 |
| Nasdaq listing fee                             |     |        |   270,000 |
| Printing and engraving expenses                |     |        |   400,000 |
| Legal fees and expenses                        |     |        | 1,935,000 |
| Accounting fees and expenses                   |     |        |   550,000 |
| Transfer agent and registrar fees and expenses |     |        |     5,000 |
| Miscellaneous fees and expenses                |     |        |   746,549 |
| Total                                          |     | $      | 4